Soekjoong Kim | R&D Managing Director

Soekjoong Kim, R&D Managing Director, ToolGen

Seokjoong Kim is an experienced molecular biologist in the field of programmable nuclease development and genome editing technology. Currently, Seokjoong is leading research and business development of ToolGen, Inc., Korean biotech focused on the translation of CRISPR/Cas9 technology into valuable products in the field of therapeutics. Following his Ph.D. studies in Molecular Medicine at University of Texas Health Science Center at San Antonio, Seokjoong joined the group of Prof. Jin-Soo Kim at Seoul National University as a postdoctoral researcher where he started a career in genome editing with the development of zinc finger nucleases and TAL effector nucleases. 

back to speakers